Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-03-19

FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)

View source ↗

Summary

FDA approved a supplemental application for AndroGel (testosterone) by ASCEND Therapeutics U.S., LLC to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANDROGEL (Testosterone)

Snippet

SUPPL AP for ANDROGEL (TESTOSTERONE)